Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Jennens

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2022
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancerChia Yuen Chong, Azim Jalali, Hui Li Wong, et al.
BMJ Supportive & Palliative Care|February 22, 2023
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind studyMeera R Agar, Anna K Nowak, Elizabeth J Hovey, et al.
The Lancet. Oncology|March 31, 2022
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trialHedy L Kindler, Silvia Novello, Alessandra Bearz, et al.
Neuro-Oncology Advances|October 16, 2023
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastomaHao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.
Clinical Colorectal Cancer|March 13, 2016
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal CancerHui-Li Wong, Belinda Lee, Kathryn Field, et al.
Asia-Pacific Journal of Clinical Oncology|November 26, 2016
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort studyBelinda Lee, Hui-Li Wong, Mark Tacey, et al.
Internal Medicine Journal|November 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancerMatthew Loft, Vanessa Wong, Suzanne Kosmider, et al.
Asia-Pacific Journal of Clinical Oncology|January 24, 2022
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancerChia Yuen Chong, Azim Jalali, Hui Li Wong, et al.
BMJ Supportive & Palliative Care|February 22, 2023
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind studyMeera R Agar, Anna K Nowak, Elizabeth J Hovey, et al.
The Lancet. Oncology|March 31, 2022
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trialHedy L Kindler, Silvia Novello, Alessandra Bearz, et al.
Neuro-Oncology Advances|October 16, 2023
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastomaHao-Wen Sim, Luke Wachsmuth, Elizabeth H Barnes, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Pageof 2